Compounds > gadolinium
Page last updated: 2024-08-22

gadolinium and Fatty Liver, Nonalcoholic

gadolinium has been researched along with Fatty Liver, Nonalcoholic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Caravan, P; Chen, YI; Erstad, DJ; Ferreira, DS; Fuchs, BC; Jones, CM; Martinez, RVP; Masia, R; Rotile, NJ; Schlerman, F; Sojoodi, M; Tanabe, KK; Tu, C; Waghorn, PA; Wellen, J1
Barrau, V; Beers, BV; Meskine, N; Piana, G; Trinquart, L; Vilgrain, V1
Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lin, HC; Tsai, TH; Yang, YY1

Other Studies

3 other study(ies) available for gadolinium and Fatty Liver, Nonalcoholic

ArticleYear
Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis.
    Scientific reports, 2021, 03-17, Volume: 11, Issue:1

    Topics: Animals; Contrast Media; Coordination Complexes; Diet, High-Fat; Disease Models, Animal; Gadolinium; Liver; Magnetic Resonance Imaging; Male; Mice; Non-alcoholic Fatty Liver Disease

2021
New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases.
    Journal of hepatology, 2011, Volume: 55, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diffusion Magnetic Resonance Imaging; Fatty Liver; Female; Gadolinium; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis, Alcoholic; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Observer Variation

2011
Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis.
    Clinical science (London, England : 1979), 2012, Volume: 123, Issue:12

    Topics: Analysis of Variance; Animals; Arachidonic Acid; Benzofurans; Choline; Clodronic Acid; Diet, High-Fat; DNA Primers; Fatty Acids, Unsaturated; Fatty Liver; Gadolinium; Hemodynamics; Hypertension, Portal; Insulin Resistance; Kupffer Cells; Leptin; Methionine; Methoxamine; Microcirculation; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Receptors, Thromboxane A2, Prostaglandin H2; RNA, Messenger; Sulfonylurea Compounds; Thiobarbituric Acid Reactive Substances; Thromboxane A2

2012